Global Respiratory Virus Activity: Weekly Update N° 604
Week 45, ending 08 November 2026
Overview
In week 45 2026, globally, influenza positivity was just above 10% and SARS-CoV-2 positivity remained low. Influenza positivity continued to increase to over 10% in the northern hemisphere temperate and subtropical areas. Influenza positivity remained at 5% in the southern hemisphere temperate and subtropical areas and decreased but remained above 10% in the tropical areas. RSV positivity also remained low globally.
Influenza
Globally, influenza detections increased slightly over the past few weeks but remained low with influenza A virus detections predominant in week 45.
In the northern hemisphere, influenza percent positivity was elevated (>10%) in some countries in Central America and the Caribbean, Northern Europe and Western, Southern, South-East and Eastern Asia and in a single countries in Eastern Europe and Western and Middle Africa. Percent positivity was over 30% in some countries in Central America and the Caribbean, Western and Southern Asia and in single countries in Western Africa and South-East Asia. Increases in activity were observed in some countries in Central America and the Caribbean and in single countries in Northern and Eastern Europe, Western Africa and Western, Southern and South-East Asia.
In the southern hemisphere, influenza percent positivity was elevated (>10%) in some countries in Tropical South America and Oceania and in single countries in Eastern Africa and Oceania. Percent positivity was over 30% in a single country in South-East Asia.
In the zones with elevated positivity, influenza A(H1N1)pdm09 was predominant in Northern and Eastern Europe, Eastern Africa, Western, South-East and Eastern Asia, and Oceania. Influenza A and B were codominant in Central America and the Caribbean and Southern Asia and influenza B was predominant in Tropical South America and Western and Middle Africa.
SARS-CoV-2
Globally, SARS-CoV-2 positivity remained stable and low across most reporting countries, with elevated positivity (>10%) reported in some countries in Central America and the Caribbean and South West Europe, and in single countries in Temperate South America, Northern and Eastern Europe, and Western Asia. Percent positivity was over 30% in one country in Northern Africa. Small increases in activity were observed in single countries in Northern, South West and Eastern Europe, and Western Asia.
Respiratory Syncytial Virus (RSV)
RSV positivity was elevated (>10%) in a few countries in Central America and the Caribbean and Tropical South America, and in single countries in Western Africa and Southern Asia. Percent positivity was over 30% in a single country in Southern Asia. A small increase in activity was observed in a single country in Central America and the Caribbean. RSV and influenza activity were both elevated in some countries in Central America and the Caribbean and in a single country in Southern Asia.
Severity assessment
The severity assessments here are reported from countries, areas and territories. Assessments for transmissibility can be reported based on syndromic parameters and/or influenza-specific parameters. In the northern hemisphere temperate and subtropical areas, influenza-specific transmissibility was reported as below seasonal threshold in 15 countries and low in 11 countries; transmissibility using syndromic data was reported as below seasonal threshold in six countries and low in three countries. Influenza-specific transmissibility was reported as below threshold in two countries in the tropical areas.
WHO encourages countries, especially those that have received the multiplex influenza and SARS-CoV-2 reagent kits from GISRS, to conduct integrated surveillance of influenza and SARS-CoV-2 and report epidemiological and laboratory information in a timely manner to established regional and global platforms. The guidance can be found here.
Starting with report #501, the Global Respiratory Virus Activity Weekly Update included data from sentinel surveillance and other types of systematically conducted virologic surveillance. Countries, areas, and territories use a variety of approaches to monitor respiratory virus activity and data in this report may vary from surveillance reports posted elsewhere. Analyses stratified by source of surveillance is available through Respimart.